Iterum Therapeutics plc
ITRMDelisted Jun 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659323
Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding Iterum Therapeutics plc changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 18 | 15 | −3 |
| Shares | 928.8K | 431.6K | −497.2K (−53.5%) |
| Value | $1.43M | $494.7K | −$935.6K (−65.4%) |
New holders (3)
Institutions that held Iterum Therapeutics plc at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 38,483 | $44.6K | 0.00% |
| Activest Wealth Management | 133 | $152 | 0.00% |
| Planning Capital Management Corp | 40 | $46 | 0.00% |
Sold out (6)
Institutions that held Iterum Therapeutics plc at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Point72 Asset Management, L.P. | 434,000 | $668.4K |
| Millennium Management LLC | 28,043 | $43.2K |
| Vontobel Holding Ltd. | 15,000 | $23.1K |
| Ancora Advisors, LLC | 38 | $59 |
| Larson Financial Group LLC | 13 | $20 |
| Royal Bank of Canada | 100 | $0 |